FIRM ANALYSIS FINANCE & TRANSACTIONAL
Firm Briefings
SPECIALTY OVERVIEW
We asked finance & transactional attorneys to tell us whether they had experience in certain areas. The following represents a percentage of all respondents’ answers.
Agricultural Biotechnology Allergenics Antibiotics Antibodies Antivivral Drugs Biofuels Biologics Biosimilars Cardiovascular Devices Cellular & Gene Therapy Products CNS and anti-allergy Drugs Combination Products Cosmetic Devices Dental Devices Detection Technologies Diagnostics DNA Sequencing Drug Delivery Devices Drug Formulations Electronic Medical Records General Hospital Devices and Supplies Generic Drugs Genetically Modified Plants Hematology Products Home Health and Consumer Devices Imaging Devices Implants and Prosthetics In Vitro Diagnostics Large Molecules Lipids Macromolecules Mobile Medical Applications Neurology Devices Neurovascular Devices New Chemical Entities Oncology Drugs Ophthalmology Devices Orphan Drugs Orthopedic Devices Pediatric Medical Devices Personalized Medicine Proteins/Proteomics Recombinant DNA Regenerative Medicine Respiratory Devices Small Molecules Spinal Implants Surgery and Life Support Devices Tissue & Tissue Products Transgenic Plant Biotechnology Vaccines
0
10
20
30
40
50
LMG LIFE SCIENCES 2013
93